Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Arrhythmias

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 191 articles:
HTML format
Text format



Single Articles


    January 2019
  1. WALL C, Jankowski T, Naruka V, Mota P, et al
    Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter.
    PLoS One. 2019;14:e0210170.
    PubMed     Text format     Abstract available


  2. MATSUMOTO Y, Mori Y, Kageyama S, Arihara K, et al
    Changes in QTc interval in long-term hemodialysis patients.
    PLoS One. 2019;14:e0209297.
    PubMed     Text format     Abstract available


    January 2018
  3. BREMBILLA-PERROT B, Sellal JM, Olivier A, Villemin T, et al
    Influence of advancing age on clinical presentation, treatment efficacy and safety, and long-term outcome of inducible paroxysmal supraventricular tachycardia without pre-excitation syndromes: A cohort study of 1960 patients included over 25 years.
    PLoS One. 2018;13:e0187895.
    PubMed     Text format     Abstract available


  4. JIANG YQ, Tian Y, Zeng LJ, He SN, et al
    The safety and efficacy of hybrid ablation for the treatment of atrial fibrillation: A meta-analysis.
    PLoS One. 2018;13:e0190170.
    PubMed     Text format     Abstract available


  5. BEGG GA, Karim R, Oesterlein T, Graham LN, et al
    Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study.
    PLoS One. 2018;13:e0189936.
    PubMed     Text format     Abstract available


  6. SALIBA W, Rennert HS, Gronich N, Gruber SB, et al
    Association of atrial fibrillation and cancer: Analysis from two large population-based case-control studies.
    PLoS One. 2018;13:e0190324.
    PubMed     Text format     Abstract available


  7. KUCUKSEYMEN S, Cekin AH, Bayar N, Arslan S, et al
    A novel biomarker for prediction of atrial fibrillation susceptibility in patients with celiac disease.
    PLoS One. 2018;13:e0190382.
    PubMed     Text format     Abstract available


  8. FAYSSOIL A, Ben Yaou R, Ogna A, Chaffaut C, et al
    Left bundle branch block in Duchenne muscular dystrophy: Prevalence, genetic relationship and prognosis.
    PLoS One. 2018;13:e0190518.
    PubMed     Text format     Abstract available


  9. MARTIN B, Gabris-Weber BA, Reddy R, Romero G, et al
    Relaxin reverses inflammatory and immune signals in aged hearts.
    PLoS One. 2018;13:e0190935.
    PubMed     Text format     Abstract available


  10. LI X, Keshishian A, Hamilton M, Horblyuk R, et al
    Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach.
    PLoS One. 2018;13:e0191722.
    PubMed     Text format     Abstract available


  11. XU Y, Shoamanesh A, Schulman S, Dowlatshahi D, et al
    Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts.
    PLoS One. 2018;13:e0191137.
    PubMed     Text format     Abstract available


  12. CHOU CC, Lee HL, Chang PC, Wo HT, et al
    Left atrial emptying fraction predicts recurrence of atrial fibrillation after radiofrequency catheter ablation.
    PLoS One. 2018;13:e0191196.
    PubMed     Text format     Abstract available


  13. WANG X, Wang C, Ye M, Lin J, et al
    Left atrial concomitant surgical ablation for treatment of atrial fibrillation in cardiac surgery: A meta-analysis of randomized controlled trials.
    PLoS One. 2018;13:e0191354.
    PubMed     Text format     Abstract available


  14. KIM YG, Choi JI, Kim MN, Cho DH, et al
    Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study.
    PLoS One. 2018;13:e0191648.
    PubMed     Text format     Abstract available


  15. OSADCHII OE
    Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals.
    PLoS One. 2018;13:e0191514.
    PubMed     Text format     Abstract available


  16. EGGIMANN L, Blum S, Aeschbacher S, Reusser A, et al
    Risk factors for heart failure hospitalizations among patients with atrial fibrillation.
    PLoS One. 2018;13:e0191736.
    PubMed     Text format     Abstract available


  17. DONOVAN TM, Katz JE
    AMModels: An R package for storing models, data, and metadata to facilitate adaptive management.
    PLoS One. 2018;13:e0188966.
    PubMed     Text format     Abstract available


  18. BASSAND JP, Accetta G, Al Mahmeed W, Corbalan R, et al
    Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
    PLoS One. 2018;13:e0191592.
    PubMed     Text format     Abstract available


  19. CHARLTON B, Adeboyeje G, Barron JJ, Grady D, et al
    Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban.
    PLoS One. 2018;13:e0193912.
    PubMed     Text format     Abstract available


  20. VAN MIERT JHA, Bos S, Veeger NJGM, Meijer K, et al
    Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis.
    PLoS One. 2018;13:e0194208.
    PubMed     Text format     Abstract available


  21. LING X, Zhou H, Ni Y, Wu C, et al
    Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials.
    PLoS One. 2018;13:e0193303.
    PubMed     Text format     Abstract available


  22. SKOWASCH D, Ringquist S, Nickenig G, Andrie R, et al
    Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    PLoS One. 2018;13:e0194496.
    PubMed     Text format     Abstract available


  23. HANSEN PW, Sehested TSG, Fosbol EL, Torp-Pedersen C, et al
    Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011.
    PLoS One. 2018;13:e0194295.
    PubMed     Text format     Abstract available


  24. NAKAMIZO T, Yamamoto M, Johkura K
    Changes in stroke risk by freedom-from-stroke time in simulated populations with atrial fibrillation: Freedom-from-event effect when event itself is a risk factor.
    PLoS One. 2018;13:e0194307.
    PubMed     Text format     Abstract available


  25. KULKARNI K, Xie X, Fernandez de Velasco EM, Anderson A, et al
    The influences of the M2R-GIRK4-RGS6 dependent parasympathetic pathway on electrophysiological properties of the mouse heart.
    PLoS One. 2018;13:e0193798.
    PubMed     Text format     Abstract available


  26. MCHORNEY CA, Crivera C, Laliberte F, Germain G, et al
    Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.
    PLoS One. 2018;13:e0194099.
    PubMed     Text format     Abstract available


  27. BIAN S, Chen H, Wang L, Fei Y, et al
    Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.
    PLoS One. 2018;13:e0194397.
    PubMed     Text format     Abstract available


  28. SETHI NJ, Nielsen EE, Safi S, Feinberg J, et al
    Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    PLoS One. 2018;13:e0193924.
    PubMed     Text format     Abstract available


  29. SEONG CS, Gwag HB, Hwang JK, Park SJ, et al
    Clinical significance of fragmented QRS complexes or J waves in patients with idiopathic ventricular arrhythmias.
    PLoS One. 2018;13:e0194363.
    PubMed     Text format     Abstract available


  30. GRAY B, Gnanappa GK, Bagnall RD, Femia G, et al
    Relations between right ventricular morphology and clinical, electrical and genetic parameters in Brugada Syndrome.
    PLoS One. 2018;13:e0195594.
    PubMed     Text format     Abstract available


  31. CHALAZAN B, Mol D, Sridhar A, Alzahrani Z, et al
    Genetic modulation of atrial fibrillation risk in a Hispanic/Latino cohort.
    PLoS One. 2018;13:e0194480.
    PubMed     Text format     Abstract available


  32. LIP GYH, Pan X, Kamble S, Kawabata H, et al
    Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.
    PLoS One. 2018;13:e0195950.
    PubMed     Text format     Abstract available


  33. MARCONDES L, Crawford J, Earle N, Smith W, et al
    Long QT molecular autopsy in sudden unexplained death in the young (1-40 years old): Lessons learnt from an eight year experience in New Zealand.
    PLoS One. 2018;13:e0196078.
    PubMed     Text format     Abstract available


  34. TURAKHIA MP, Shafrin J, Bognar K, Trocio J, et al
    Estimated prevalence of undiagnosed atrial fibrillation in the United States.
    PLoS One. 2018;13:e0195088.
    PubMed     Text format     Abstract available


  35. DALGAARD F, Ruwald MH, Lindhardt TB, Gislason GH, et al
    Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy.
    PLoS One. 2018;13:e0195175.
    PubMed     Text format     Abstract available


  36. SANDERS JM, Steverson AB, Pawlowski AE, Schneider D, et al
    Atrial arrhythmia prevalence and characteristics for human immunodeficiency virus-infected persons and matched uninfected controls.
    PLoS One. 2018;13:e0194754.
    PubMed     Text format     Abstract available


  37. KRAUS M, Physick-Sheard P, Brito LF, Sargolzaei M, et al
    Marginal ancestral contributions to atrial fibrillation in the Standardbred racehorse: Comparison of cases and controls.
    PLoS One. 2018;13:e0197137.
    PubMed     Text format     Abstract available


  38. DANILOWICZ-SZYMANOWICZ L, Kaufmann D, Rozwadowska K, Kempa M, et al
    Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction.
    PLoS One. 2018;13:e0196812.
    PubMed     Text format     Abstract available


  39. DONATE PUERTAS R, Jalabert A, Meugnier E, Euthine V, et al
    Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation.
    PLoS One. 2018;13:e0196666.
    PubMed     Text format     Abstract available


  40. JUNG Y, Cho Y, Kim N, Oh IY, et al
    Lipidomic profiling reveals free fatty acid alterations in plasma from patients with atrial fibrillation.
    PLoS One. 2018;13:e0196709.
    PubMed     Text format     Abstract available


  41. MENDOZA-SANCHEZ J, Silva F, Rangel L, Jaramillo L, et al
    Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis.
    PLoS One. 2018;13:e0196361.
    PubMed     Text format     Abstract available


  42. YANG T, Yu L, Jin Q, Wu L, et al
    Activation recovery interval imaging of premature ventricular contraction.
    PLoS One. 2018;13:e0196916.
    PubMed     Text format     Abstract available


  43. CALVO M, Romero D, Le Rolle V, Behar N, et al
    Multivariate classification of Brugada syndrome patients based on autonomic response to exercise testing.
    PLoS One. 2018;13:e0197367.
    PubMed     Text format     Abstract available


  44. SIM MA, Liu W, Chew STH, Ti LK, et al
    Wider perioperative glycemic fluctuations increase risk of postoperative atrial fibrillation and ICU length of stay.
    PLoS One. 2018;13:e0198533.
    PubMed     Text format     Abstract available


  45. LEE HJ, Uhm JS, Hong YJ, Hur J, et al
    Altered myocardial characteristics of the preexcited segment in Wolff-Parkinson-White syndrome: A pilot study with cardiac magnetic resonance imaging.
    PLoS One. 2018;13:e0198218.
    PubMed     Text format     Abstract available


  46. MAKAM RCP, Hoaglin DC, McManus DD, Wang V, et al
    Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.
    PLoS One. 2018;13:e0197583.
    PubMed     Text format     Abstract available


  47. LIU J, Bayer JD, Aschar-Sobbi R, Wauchop M, et al
    Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    PLoS One. 2018;13:e0197273.
    PubMed     Text format     Abstract available


  48. GWAG HB, Chun KJ, Hwang JK, Park SJ, et al
    Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients.
    PLoS One. 2018;13:e0197352.
    PubMed     Text format     Abstract available


  49. HUNG CS, Chang CH, Lin JW, Ho YL, et al
    The association between new onset atrial fibrillation and incident cancer-A nationwide cohort study.
    PLoS One. 2018;13:e0199901.
    PubMed     Text format     Abstract available


  50. GHAZAL F, Theobald H, Rosenqvist M, Al-Khalili F, et al
    Feasibility and outcomes of atrial fibrillation screening using intermittent electrocardiography in a primary healthcare setting: A cross-sectional study.
    PLoS One. 2018;13:e0198069.
    PubMed     Text format     Abstract available


  51. PAPPAS MA, Vijan S, Rothberg MB, Singer DE, et al
    Reducing age bias in decision analyses of anticoagulation for patients with nonvalvular atrial fibrillation - A microsimulation study.
    PLoS One. 2018;13:e0199593.
    PubMed     Text format     Abstract available


  52. DOBKOWSKA-CHUDON W, Wrobel M, Karlowicz P, Dabrowski A, et al
    Detecting cerebrovascular changes in the brain caused by hypertension in atrial fibrillation group using acoustocerebrography.
    PLoS One. 2018;13:e0199999.
    PubMed     Text format     Abstract available


  53. KAO WF, Hou SK, Huang CY, Chao CC, et al
    Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: An unblinded clinical trial.
    PLoS One. 2018;13:e0198852.
    PubMed     Text format     Abstract available


  54. FERNANDES FM, Silva EP, Martins RR, Oliveira AG, et al
    QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications.
    PLoS One. 2018;13:e0199028.
    PubMed     Text format     Abstract available


  55. YANG PS, Pak HN, Park DH, Yoo J, et al
    Non-cardioembolic risk factors in atrial fibrillation-associated ischemic stroke.
    PLoS One. 2018;13:e0201062.
    PubMed     Text format     Abstract available


  56. KIM DH, Lee DI, Ahn J, Lee KN, et al
    Ischemic stroke risk during long-term follow up in patients with successful catheter ablation for atrial fibrillation in Korea.
    PLoS One. 2018;13:e0201061.
    PubMed     Text format     Abstract available


  57. SHIMAMOTO K, Miura F, Shimatani Y, Nishioka K, et al
    Pulmonary vein volume predicts the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation.
    PLoS One. 2018;13:e0201199.
    PubMed     Text format     Abstract available


  58. COLL M, Ferrer-Costa C, Pich S, Allegue C, et al
    Role of genetic and electrolyte abnormalities in prolonged QTc interval and sudden cardiac death in end-stage renal disease patients.
    PLoS One. 2018;13:e0200756.
    PubMed     Text format     Abstract available


  59. SHAHID F, Rahmat NA, Lip GYH, Shantsila E, et al
    Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project.
    PLoS One. 2018;13:e0200373.
    PubMed     Text format     Abstract available


  60. MAYHUGH RE, Laurienti PJ, Fanning J, Gauvin L, et al
    Cardiac vagal dysfunction moderates patterns of craving across the day in moderate to heavy consumers of alcohol.
    PLoS One. 2018;13:e0200424.
    PubMed     Text format     Abstract available


  61. CLEMENTY N, Garcia B, Andre C, Bisson A, et al
    Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure.
    PLoS One. 2018;13:e0201517.
    PubMed     Text format     Abstract available


  62. LIOU YS, Yang FY, Chen HY, Jong GP, et al
    Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study.
    PLoS One. 2018;13:e0197245.
    PubMed     Text format     Abstract available


  63. GULATI S, Solheim O, Carlsen SM, Oie LR, et al
    Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study.
    PLoS One. 2018;13:e0202575.
    PubMed     Text format     Abstract available


  64. CLASEN L, Eickholt C, Angendohr S, Jungen C, et al
    A modified approach for programmed electrical stimulation in mice: Inducibility of ventricular arrhythmias.
    PLoS One. 2018;13:e0201910.
    PubMed     Text format     Abstract available


  65. MA R, Qin Z, Yu X, Liu S, et al
    Selective ablation of the ligament of Marshall reduces ischemia and reperfusion-induced ventricular arrhythmias.
    PLoS One. 2018;13:e0203083.
    PubMed     Text format     Abstract available


  66. SANDGREN E, Rorsman C, Edvardsson N, Engdahl J, et al
    Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation.
    PLoS One. 2018;13:e0203661.
    PubMed     Text format     Abstract available


  67. CLAXTON JS, MacLehose RF, Lutsey PL, Norby FL, et al
    A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants.
    PLoS One. 2018;13:e0203599.
    PubMed     Text format     Abstract available


  68. TOMOMORI S, Nakano Y, Ochi H, Onohara Y, et al
    Maintenance of low inflammation level by the ZFHX3 SNP rs2106261 minor allele contributes to reduced atrial fibrillation recurrence after pulmonary vein isolation.
    PLoS One. 2018;13:e0203281.
    PubMed     Text format     Abstract available


  69. HUNTER MD, Park Moon Y, DeCarli C, Gutierrez J, et al
    Electrocardiographic left atrial abnormality and silent vascular brain injury: The Northern Manhattan Study.
    PLoS One. 2018;13:e0203774.
    PubMed     Text format     Abstract available


  70. MIYAZAKI M, Nakashima A, Nakamura Y, Sakamoto Y, et al
    Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: An observational cross-sectional pilot study.
    PLoS One. 2018;13:e0204814.
    PubMed     Text format     Abstract available


  71. RIBEIRO WN, Yamada AT, Grupi CJ, da Silva GT, et al
    Premature atrial and ventricular complexes in outpatients referred from a primary care facility.
    PLoS One. 2018;13:e0204246.
    PubMed     Text format     Abstract available


  72. LIU LB, Guo YD, Xu AD, Zhong JX, et al
    Diagnostic value of STAF score in combination with D-dimer in cardioembolism.
    PLoS One. 2018;13:e0204838.
    PubMed     Text format     Abstract available


  73. GROPLER MRF, Dalal AS, Van Hare GF, Silva JNA, et al
    Can smartphone wireless ECGs be used to accurately assess ECG intervals in pediatrics? A comparison of mobile health monitoring to standard 12-lead ECG.
    PLoS One. 2018;13:e0204403.
    PubMed     Text format     Abstract available


  74. KIM D, Shim CY, Hong GR, Cho IJ, et al
    Sinus node dysfunction after surgical atrial fibrillation ablation with concomitant mitral valve surgery: Determinants and clinical outcomes.
    PLoS One. 2018;13:e0203828.
    PubMed     Text format     Abstract available


  75. KUBOTA K, Ooba N, Kamijima Y, Sato K, et al
    The use of anticoagulants in patients with non-valvular atrial fibrillation between 2005 and 2014: A drug utilization study using claims data in Japan.
    PLoS One. 2018;13:e0203380.
    PubMed     Text format     Abstract available


  76. DE VREESE LP, Mantesso U, De Bastiani E, Marangoni A, et al
    Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study.
    PLoS One. 2018;13:e0205897.
    PubMed     Text format     Abstract available


  77. MARZEC L, Raghavan S, Banaei-Kashani F, Creasy S, et al
    Device-measured physical activity data for classification of patients with ventricular arrhythmia events: A pilot investigation.
    PLoS One. 2018;13:e0206153.
    PubMed     Text format     Abstract available


  78. LEE SH, Park M, Park KM, Gwag HB, et al
    Corrected QT interval on the electrocardiogram after liver transplantation: Surrogate marker of poor clinical outcomes?
    PLoS One. 2018;13:e0206463.
    PubMed     Text format     Abstract available


  79. HWANG JK, Jeong DS, Gwag HB, Park KM, et al
    Staged hybrid procedure versus radiofrequency catheter ablation in the treatment of atrial fibrillation.
    PLoS One. 2018;13:e0205431.
    PubMed     Text format     Abstract available


  80. KATTELUS H, Kesaniemi YA, Huikuri H, Ukkola O, et al
    Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study).
    PLoS One. 2018;13:e0205454.
    PubMed     Text format     Abstract available


  81. MORELLATO J, Chik W, Barry MA, Lu J, et al
    Quantitative spectral assessment of intracardiac electrogram characteristics associated with post infarct fibrosis and ventricular tachycardia.
    PLoS One. 2018;13:e0204997.
    PubMed     Text format     Abstract available


  82. TEPPER PG, Mardekian J, Masseria C, Phatak H, et al
    Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban.
    PLoS One. 2018;13:e0205989.
    PubMed     Text format     Abstract available


  83. JANG J, Tschabrunn CM, Barkagan M, Anter E, et al
    Three-dimensional holographic visualization of high-resolution myocardial scar on HoloLens.
    PLoS One. 2018;13:e0205188.
    PubMed     Text format     Abstract available


  84. KORNEJ J, Buttner P, Hammer E, Engelmann B, et al
    Circulating proteomic patterns in AF related left atrial remodeling indicate involvement of coagulation and complement cascade.
    PLoS One. 2018;13:e0198461.
    PubMed     Text format     Abstract available


  85. HE J, Sun L, Rong J, Wang H, et al
    A pyramid-like model for heartbeat classification from ECG recordings.
    PLoS One. 2018;13:e0206593.
    PubMed     Text format     Abstract available


  86. ROSTON TM, Haji-Ghassemi O, LaPage MJ, Batra AS, et al
    Catecholaminergic polymorphic ventricular tachycardia patients with multiple genetic variants in the PACES CPVT Registry.
    PLoS One. 2018;13:e0205925.
    PubMed     Text format     Abstract available


  87. SCHUMACHER K, Buttner P, Dagres N, Sommer P, et al
    Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation.
    PLoS One. 2018;13:e0206933.
    PubMed     Text format     Abstract available


  88. SHAO M, Shang L, Shi J, Zhao Y, et al
    The safety and efficacy of second-generation cryoballoon ablation plus catheter ablation for persistent atrial fibrillation: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0206362.
    PubMed     Text format     Abstract available


  89. LIU L, Huang J, Zhang X, Tang X, et al
    Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis.
    PLoS One. 2018;13:e0199232.
    PubMed     Text format     Abstract available


  90. BAE HJ, Heo JH, Jung KH, Lee YS, et al
    Antithrombotic treatments in patients with acute ischemic stroke and non-valvular atrial fibrillation before introduction of non-vitamin K antagonist oral anticoagulants into practice in Korea.
    PLoS One. 2018;13:e0202803.
    PubMed     Text format     Abstract available


  91. AU-YEUNG WM, Reinhall PG, Bardy GH, Brunton SL, et al
    Development and validation of warning system of ventricular tachyarrhythmia in patients with heart failure with heart rate variability data.
    PLoS One. 2018;13:e0207215.
    PubMed     Text format     Abstract available


  92. JUNG YH, Kim YD, Kim J, Han SW, et al
    Atrial fibrillation in patients with first-ever stroke: Incidence trends and antithrombotic therapy before the event.
    PLoS One. 2018;13:e0209198.
    PubMed     Text format     Abstract available


    January 2017
  93. JAIN V, Marshall IJ, Crichton SL, McKevitt C, et al
    Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014.
    PLoS One. 2017;12:e0175980.
    PubMed     Text format     Abstract available


  94. ALDHOON B, Wichterle D, Peichl P, Cihak R, et al
    Outcomes of ventricular tachycardia ablation in patients with structural heart disease: The impact of electrical storm.
    PLoS One. 2017;12:e0171830.
    PubMed     Text format     Abstract available


  95. TAN D, Xu J, Shao S, Fu Y, et al
    Comparison of different inspiratory triggering settings in automated ventilators during cardiopulmonary resuscitation in a porcine model.
    PLoS One. 2017;12:e0171869.
    PubMed     Text format     Abstract available


  96. MACIANSKIENE R, Almanaityte M, Jekabsone A, Mubagwa K, et al
    Modulation of Human Cardiac TRPM7 Current by Extracellular Acidic pH Depends upon Extracellular Concentrations of Divalent Cations.
    PLoS One. 2017;12:e0170923.
    PubMed     Text format     Abstract available


  97. KORNEJ J, Hindricks G, Arya A, Sommer P, et al
    The APPLE Score - A Novel Score for the Prediction of Rhythm Outcomes after Repeat Catheter Ablation of Atrial Fibrillation.
    PLoS One. 2017;12:e0169933.
    PubMed     Text format     Abstract available


  98. ANSELMINO M, Scarsoglio S, Saglietto A, Gaita F, et al
    A Computational Study on the Relation between Resting Heart Rate and Atrial Fibrillation Hemodynamics under Exercise.
    PLoS One. 2017;12:e0169967.
    PubMed     Text format     Abstract available


  99. KONIGSBRUGGE O, Posch F, Antlanger M, Kovarik J, et al
    Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).
    PLoS One. 2017;12:e0169400.
    PubMed     Text format     Abstract available


  100. KARAJAMAKI AJ, Kettunen O, Lepojarvi S, Koivurova OP, et al
    Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.
    PLoS One. 2017;12:e0173855.
    PubMed     Text format     Abstract available


  101. KORHONEN M, Parkkonen J, Hedman M, Muuronen A, et al
    Morphological features of the left atrial appendage in consecutive coronary computed tomography angiography patients with and without atrial fibrillation.
    PLoS One. 2017;12:e0173703.
    PubMed     Text format     Abstract available


  102. FARRE N, Vela E, Cleries M, Bustins M, et al
    Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients.
    PLoS One. 2017;12:e0172745.
    PubMed     Text format     Abstract available


  103. SKIELBOE AK, Bandholm TQ, Hakmann S, Mourier M, et al
    Cardiovascular exercise and burden of arrhythmia in patients with atrial fibrillation - A randomized controlled trial.
    PLoS One. 2017;12:e0170060.
    PubMed     Text format     Abstract available


  104. GU J, Skals RK, Torp-Pedersen C, Lundbye-Christensen S, et al
    Storage time of intraoperative transfused allogeneic red blood cells is not associated with new-onset postoperative atrial fibrillation in cardiac surgery.
    PLoS One. 2017;12:e0172726.
    PubMed     Text format     Abstract available


  105. SMORODINOVA N, Blaha M, Melenovsky V, Rozsivalova K, et al
    Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythm.
    PLoS One. 2017;12:e0172691.
    PubMed     Text format     Abstract available


  106. HENDRIKX T, Sundqvist M, Sandstrom H, Sahlin C, et al
    Atrial fibrillation among patients under investigation for suspected obstructive sleep apnea.
    PLoS One. 2017;12:e0171575.
    PubMed     Text format     Abstract available


  107. ZHANG D, Chen X, Wang Q, Wu S, et al
    Role of the MAPKs/TGF-beta1/TRAF6 signaling pathway in postoperative atrial fibrillation.
    PLoS One. 2017;12:e0173759.
    PubMed     Text format     Abstract available


  108. SILAND JE, Geelhoed B, van Gelder IC, van der Harst P, et al
    Telomere length and incident atrial fibrillation - data of the PREVEND cohort.
    PLoS One. 2017;12:e0171545.
    PubMed     Text format     Abstract available


  109. WEI W, Liao H, Xue Y, Fang X, et al
    Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience.
    PLoS One. 2017;12:e0169863.
    PubMed     Text format     Abstract available


  110. AHMED FZ, Motwani M, Cunnington C, Kwok CS, et al
    One-Month Global Longitudinal Strain Identifies Patients Who Will Develop Pacing-Induced Left Ventricular Dysfunction over Time: The Pacing and Ventricular Dysfunction (PAVD) Study.
    PLoS One. 2017;12:e0162072.
    PubMed     Text format     Abstract available


  111. JABBARI R, Glinge C, Jabbari J, Risgaard B, et al
    A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial Infarction.
    PLoS One. 2017;12:e0170193.
    PubMed     Text format     Abstract available


  112. CALLIZO J, Feltgen N, Ammermann A, Ganser J, et al
    Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathy.
    PLoS One. 2017;12:e0181766.
    PubMed     Text format     Abstract available


  113. BHATTACHARYYA S, Bhakta M, Munshi NV
    Phenotypically silent Cre recombination within the postnatal ventricular conduction system.
    PLoS One. 2017;12:e0174517.
    PubMed     Text format     Abstract available


  114. WANG M, Cai S, Ding W, Deng Y, et al
    Efficacy and effects on cardiac function of radiofrequency catheter ablation vs. direct current cardioversion of persistent atrial fibrillation with left ventricular systolic dysfunction.
    PLoS One. 2017;12:e0174510.
    PubMed     Text format     Abstract available


  115. TE AL, Higa S, Chung FP, Lin CY, et al
    The use of a novel signal analysis to identify the origin of idiopathic right ventricular outflow tract ventricular tachycardia during sinus rhythm: Simultaneous amplitude frequency electrogram transformation mapping.
    PLoS One. 2017;12:e0173189.
    PubMed     Text format     Abstract available


  116. ZHANG W, Lu M, Zhang C, Zhang R, et al
    Therapeutic hypothermia increases the risk of cardiac arrhythmia for perinatal hypoxic ischaemic encephalopathy: A meta-analysis.
    PLoS One. 2017;12:e0173006.
    PubMed     Text format     Abstract available


  117. RIAD FS, Razak E, Saba S, Shalaby A, et al
    Recent heart rate history affects QT interval duration in atrial fibrillation.
    PLoS One. 2017;12:e0172962.
    PubMed     Text format     Abstract available


  118. QI W, Zhang N, Korantzopoulos P, Letsas KP, et al
    Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression.
    PLoS One. 2017;12:e0170955.
    PubMed     Text format     Abstract available


  119. HWANG M, Lim B, Song JS, Yu HT, et al
    Ganglionated plexi stimulation induces pulmonary vein triggers and promotes atrial arrhythmogenecity: In silico modeling study.
    PLoS One. 2017;12:e0172931.
    PubMed     Text format     Abstract available


  120. KILKENNY MF, Dunstan L, Busingye D, Purvis T, et al
    Knowledge of risk factors for diabetes or cardiovascular disease (CVD) is poor among individuals with risk factors for CVD.
    PLoS One. 2017;12:e0172941.
    PubMed     Text format     Abstract available


  121. WAN H, Wu S, Yang Y, Zhu J, et al
    Plasma fibrin D-dimer and the risk of left atrial thrombus: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0172272.
    PubMed     Text format     Abstract available


  122. CHANG JY, Jung S, Park H, Han MK, et al
    Major vessel occlusion may predict subtherapeutic anticoagulation intensity and feasibility of administration of intravenous thrombolytics.
    PLoS One. 2017;12:e0170978.
    PubMed     Text format     Abstract available


  123. SHEHAB A, Zubaid M, Bhagavathula AS, Rashed WA, et al
    Sex differences in management and outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events (Gulf SAFE).
    PLoS One. 2017;12:e0175405.
    PubMed     Text format     Abstract available


  124. BROCKLEHURST P, Ni H, Zhang H, Ye J, et al
    Electro-mechanical dynamics of spiral waves in a discrete 2D model of human atrial tissue.
    PLoS One. 2017;12:e0176607.
    PubMed     Text format     Abstract available


  125. JAAKKOLA S, Nuotio I, Kiviniemi TO, Virtanen R, et al
    Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study.
    PLoS One. 2017;12:e0175975.
    PubMed     Text format     Abstract available


  126. ARTS DL, Abu-Hanna A, Medlock SK, van Weert HC, et al
    Effectiveness and usage of a decision support system to improve stroke prevention in general practice: A cluster randomized controlled trial.
    PLoS One. 2017;12:e0170974.
    PubMed     Text format     Abstract available


  127. RIZOS T, Bartsch AJ, Johnson TD, Dittgen F, et al
    Voxelwise distribution of acute ischemic stroke lesions in patients with newly diagnosed atrial fibrillation: Trigger of arrhythmia or only target of embolism?
    PLoS One. 2017;12:e0177474.
    PubMed     Text format     Abstract available


  128. ZHAI XW, Zhang L, Guo YF, Yang Y, et al
    The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat.
    PLoS One. 2017;12:e0177600.
    PubMed     Text format     Abstract available


  129. ONDRAKOVA M, Motovska Z, Waldauf P, Knot J, et al
    Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study.
    PLoS One. 2017;12:e0177519.
    PubMed     Text format     Abstract available


  130. WILLIS TA, West R, Rushforth B, Stokes T, et al
    Variations in achievement of evidence-based, high-impact quality indicators in general practice: An observational study.
    PLoS One. 2017;12:e0177949.
    PubMed     Text format     Abstract available


  131. SUKTITIPAT B, Sathirareuangchai S, Roothumnong E, Thongnoppakhun W, et al
    Molecular investigation by whole exome sequencing revealed a high proportion of pathogenic variants among Thai victims of sudden unexpected death syndrome.
    PLoS One. 2017;12:e0180056.
    PubMed     Text format     Abstract available


  132. KAESE S, Larbig R, Rohrbeck M, Frommeyer G, et al
    Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.
    PLoS One. 2017;12:e0180029.
    PubMed     Text format     Abstract available


  133. SON MK, Lim NK, Kim HW, Park HY, et al
    Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort.
    PLoS One. 2017;12:e0179687.
    PubMed     Text format     Abstract available


  134. LUO C, Wang K, Zhang H
    In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
    PLoS One. 2017;12:e0179515.
    PubMed     Text format     Abstract available


  135. CASTAN C, Munch A, Mahling M, Haffner L, et al
    Factors associated with delayed defibrillation in cardiopulmonary resuscitation: A prospective simulation study.
    PLoS One. 2017;12:e0178794.
    PubMed     Text format     Abstract available


  136. QIN M, Li L, Liu X, Liu T, et al
    Neural substrate of posterior left atrium: A novel modulation for inducibility and remodeling of atrial fibrillation in canine.
    PLoS One. 2017;12:e0176626.
    PubMed     Text format     Abstract available


  137. ANDERSSON T, Magnuson A, Bryngelsson IL, Frobert O, et al
    Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients.
    PLoS One. 2017;12:e0176846.
    PubMed     Text format     Abstract available


  138. GARCIA-GUDINO D, Landa E, Mendoza-Temis J, Albarado-Ibanez A, et al
    Enhancement of early warning properties in the Kuramoto model and in an atrial fibrillation model due to an external perturbation of the system.
    PLoS One. 2017;12:e0181953.
    PubMed     Text format     Abstract available


  139. PERSYN E, Karakachoff M, Le Scouarnec S, Le Clezio C, et al
    DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease.
    PLoS One. 2017;12:e0179364.
    PubMed     Text format     Abstract available


  140. FERRER-ALBERO A, Godoy EJ, Lozano M, Martinez-Mateu L, et al
    Non-invasive localization of atrial ectopic beats by using simulated body surface P-wave integral maps.
    PLoS One. 2017;12:e0181263.
    PubMed     Text format     Abstract available


  141. SJOGREN V, Bystrom B, Renlund H, Svensson PJ, et al
    Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study.
    PLoS One. 2017;12:e0181000.
    PubMed     Text format     Abstract available


  142. YOKOYAMA T, Lee JK, Miwa K, Opthof T, et al
    Quantification of sympathetic hyperinnervation and denervation after myocardial infarction by three-dimensional assessment of the cardiac sympathetic network in cleared transparent murine hearts.
    PLoS One. 2017;12:e0182072.
    PubMed     Text format     Abstract available


  143. LIU X, Sun L, Chen J, Jin Y, et al
    Effects of local cardiac denervation on cardiac innervation and ventricular arrhythmia after chronic myocardial infarction.
    PLoS One. 2017;12:e0181322.
    PubMed     Text format     Abstract available


  144. TAO S, Way SF, Garland J, Chrispin J, et al
    Ablation as targeted perturbation to rewire communication network of persistent atrial fibrillation.
    PLoS One. 2017;12:e0179459.
    PubMed     Text format     Abstract available


  145. MATONO T, Kutsuna S, Kato Y, Katanami Y, et al
    Role of classic signs as diagnostic predictors for enteric fever among returned travellers: Relative bradycardia and eosinopenia.
    PLoS One. 2017;12:e0179814.
    PubMed     Text format     Abstract available


  146. COLLINGS SL, Lefevre C, Johnson ME, Evans D, et al
    Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany.
    PLoS One. 2017;12:e0185642.
    PubMed     Text format     Abstract available


  147. TEMU TM, Lane KA, Shen C, Ng'ang'a L, et al
    Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya.
    PLoS One. 2017;12:e0185204.
    PubMed     Text format     Abstract available


  148. LACKERMAIR K, Clauss S, Voigt T, Klier I, et al
    Alteration of Endothelin 1, MCP-1 and Chromogranin A in patients with atrial fibrillation undergoing pulmonary vein isolation.
    PLoS One. 2017;12:e0184337.
    PubMed     Text format     Abstract available


  149. FARRELL M, Yoneda Z, Montgomery J, Crawford D, et al
    Non-pulmonary vein mediated atrial fibrillation: A novel sub-phenotype.
    PLoS One. 2017;12:e0184354.
    PubMed     Text format     Abstract available


  150. SPRENKELER DJ, Tuinenburg AE, Ritsema van Eck HJ, Malik M, et al
    Circadian pattern of short-term variability of the QT-interval in primary prevention ICD patients - EU-CERT-ICD methodological pilot study.
    PLoS One. 2017;12:e0183199.
    PubMed     Text format     Abstract available


  151. SONG JS, Wi J, Lee HJ, Hwang M, et al
    Role of atrial wall thickness in wave-dynamics of atrial fibrillation.
    PLoS One. 2017;12:e0182174.
    PubMed     Text format     Abstract available


  152. KIENAST R, Handler M, Stoger M, Baumgarten D, et al
    Modeling hypothermia induced effects for the heterogeneous ventricular tissue from cellular level to the impact on the ECG.
    PLoS One. 2017;12:e0182979.
    PubMed     Text format     Abstract available


  153. HSIEH WH, Lin CY, Te ALD, Lo MT, et al
    A novel noninvasive surface ECG analysis using interlead QRS dispersion in arrhythmogenic right ventricular cardiomyopathy.
    PLoS One. 2017;12:e0182364.
    PubMed     Text format     Abstract available


  154. GONG X, Tang S, Li J, Zhang X, et al
    Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis.
    PLoS One. 2017;12:e0186449.
    PubMed     Text format     Abstract available


  155. NAGATA N, Sakurai T, Moriyasu S, Shimbo T, et al
    Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding.
    PLoS One. 2017;12:e0183423.
    PubMed     Text format     Abstract available


  156. KANG HJ, Kim SW, Son SH
    The feasibility of a heart block with an electron compensation as an alternative whole breast radiotherapy technique in patients with underlying cardiac or pulmonary disease.
    PLoS One. 2017;12:e0184137.
    PubMed     Text format     Abstract available


  157. HERMANS BJM, Vink AS, Bennis FC, Filippini LH, et al
    The development and validation of an easy to use automatic QT-interval algorithm.
    PLoS One. 2017;12:e0184352.
    PubMed     Text format     Abstract available


  158. CHEN X, Qin M, Jiang W, Zhang Y, et al
    Electrophysiological characteristics of pressure overload-induced cardiac hypertrophy and its influence on ventricular arrhythmias.
    PLoS One. 2017;12:e0183671.
    PubMed     Text format     Abstract available


  159. HUSSER D, Ueberham L, Hindricks G, Buttner P, et al
    Rare variants in genes encoding the cardiac sodium channel and associated compounds and their impact on outcome of catheter ablation of atrial fibrillation.
    PLoS One. 2017;12:e0183690.
    PubMed     Text format     Abstract available


  160. DIXIT S, Alonso A, Vittinghoff E, Soliman E, et al
    Past alcohol consumption and incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study.
    PLoS One. 2017;12:e0185228.
    PubMed     Text format     Abstract available


  161. MANTOVANI A, Rigolon R, Pichiri I, Bonapace S, et al
    Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.
    PLoS One. 2017;12:e0185459.
    PubMed     Text format     Abstract available


  162. LIU Y, Wei J, Wong King Yuen SM, Sun B, et al
    CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression.
    PLoS One. 2017;12:e0184177.
    PubMed     Text format     Abstract available


  163. MERCADER MA, He D, Sharma AC, Marchitto MC, et al
    Selective autonomic stimulation of the AV node fat pad to control rapid post-operative atrial arrhythmias.
    PLoS One. 2017;12:e0183804.
    PubMed     Text format     Abstract available


  164. KHARCHE SR, Vigmond E, Efimov IR, Dobrzynski H, et al
    Computational assessment of the functional role of sinoatrial node exit pathways in the human heart.
    PLoS One. 2017;12:e0183727.
    PubMed     Text format     Abstract available


  165. ALVES-CABRATOSA L, Garcia-Gil M, Comas-Cufi M, Ponjoan A, et al
    Statins and new-onset atrial fibrillation in a cohort of patients with hypertension. Analysis of electronic health records, 2006-2015.
    PLoS One. 2017;12:e0186972.
    PubMed     Text format     Abstract available


  166. AHN J, Kim HJ, Choi JI, Lee KN, et al
    Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis.
    PLoS One. 2017;12:e0185680.
    PubMed     Text format     Abstract available


  167. KOENE RJ, Norby FL, Maheshwari A, Rooney MR, et al
    Predictors of sudden cardiac death in atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.
    PLoS One. 2017;12:e0187659.
    PubMed     Text format     Abstract available


  168. QUINTANA-VILLAMANDOS B, Gomez de Diego JJ, Delgado-Martos MJ, Munoz-Valverde D, et al
    Dronedarone produces early regression of myocardial remodelling in structural heart disease.
    PLoS One. 2017;12:e0188442.
    PubMed     Text format     Abstract available


  169. HALD J, Poulsen PB, Qvist I, Holm L, et al
    Opportunistic screening for atrial fibrillation in a real-life setting in general practice in Denmark-The Atrial Fibrillation Found On Routine Detection (AFFORD) non-interventional study.
    PLoS One. 2017;12:e0188086.
    PubMed     Text format     Abstract available


  170. SETHI NJ, Feinberg J, Nielsen EE, Safi S, et al
    The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis.
    PLoS One. 2017;12:e0186856.
    PubMed     Text format     Abstract available


  171. DA SILVA AA, Hall JE, do Carmo JM
    Leptin reverses hyperglycemia and hyperphagia in insulin deficient diabetic rats by pituitary-independent central nervous system actions.
    PLoS One. 2017;12:e0184805.
    PubMed     Text format     Abstract available


  172. VESTERGAARD AS, Skjoth F, Larsen TB, Ehlers LH, et al
    The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis.
    PLoS One. 2017;12:e0188482.
    PubMed     Text format     Abstract available


  173. YANG PS, Park YA, Kim TH, Uhm JS, et al
    Which patients recur as atrial tachycardia rather than atrial fibrillation after catheter ablation of atrial fibrillation?
    PLoS One. 2017;12:e0188326.
    PubMed     Text format     Abstract available


  174. MORTENSEN LM, Lundbye-Christensen S, Schmidt EB, Calder PC, et al
    Long-chain n-3 and n-6 polyunsaturated fatty acids and risk of atrial fibrillation: Results from a Danish cohort study.
    PLoS One. 2017;12:e0190262.
    PubMed     Text format     Abstract available


  175. LEE SR, Choi EK, Han KD, Cha MJ, et al
    Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study.
    PLoS One. 2017;12:e0189495.
    PubMed     Text format     Abstract available


  176. ROBERTS PR, Zachariah D, Morgan JM, Yue AM, et al
    Monitoring of arrhythmia and sudden death in a hemodialysis population: The CRASH-ILR Study.
    PLoS One. 2017;12:e0188713.
    PubMed     Text format     Abstract available


  177. LIM B, Hwang M, Song JS, Ryu AJ, et al
    Effectiveness of atrial fibrillation rotor ablation is dependent on conduction velocity: An in-silico 3-dimensional modeling study.
    PLoS One. 2017;12:e0190398.
    PubMed     Text format     Abstract available


    January 2016
  178. SASAOKA S, Matsui T, Hane Y, Abe J, et al
    Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events.
    PLoS One. 2016;11:e0164309.
    PubMed     Text format     Abstract available


  179. YU P, Pan Y, Wang Y, Wang X, et al
    External Validation of a Case-Mix Adjustment Model for the Standardized Reporting of 30-Day Stroke Mortality Rates in China.
    PLoS One. 2016;11:e0166069.
    PubMed     Text format     Abstract available


  180. BAJAJ NS, Kalra R, Patel N, Hashim T, et al
    Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials.
    PLoS One. 2016;11:e0163608.
    PubMed     Text format     Abstract available


  181. BING R, Chow V, Lau JK, Thomas L, et al
    Prevalence of Echocardiography Use in Patients Hospitalized with Confirmed Acute Pulmonary Embolism: A Real-World Observational Multicenter Study.
    PLoS One. 2016;11:e0168554.
    PubMed     Text format     Abstract available


  182. JAAKKOLA J, Mustonen P, Kiviniemi T, Hartikainen JE, et al
    Stroke as the First Manifestation of Atrial Fibrillation.
    PLoS One. 2016;11:e0168010.
    PubMed     Text format     Abstract available


  183. HANON O, Chaussade E, Gueranger P, Gruson E, et al
    Patient-Reported Treatment Satisfaction with Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study.
    PLoS One. 2016;11:e0166218.
    PubMed     Text format     Abstract available


  184. HUNG YC, Cheng YC, Muo CH, Chiu HE, et al
    Adjuvant Chinese Herbal Products for Preventing Ischemic Stroke in Patients with Atrial Fibrillation.
    PLoS One. 2016;11:e0159333.
    PubMed     Text format     Abstract available


  185. KUSSMAN BD, Aasted CM, Yucel MA, Steele SC, et al
    Capturing Pain in the Cortex during General Anesthesia: Near Infrared Spectroscopy Measures in Patients Undergoing Catheter Ablation of Arrhythmias.
    PLoS One. 2016;11:e0158975.
    PubMed     Text format     Abstract available


  186. PALLISGAARD JL, Gislason GH, Torp-Pedersen C, Lee CJ, et al
    Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation.
    PLoS One. 2016;11:e0161768.
    PubMed     Text format     Abstract available


  187. COLEMAN CI, Tangirala M, Evers T
    Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States.
    PLoS One. 2016;11:e0157769.
    PubMed     Text format     Abstract available


  188. VENE N, Mavri A, Gubensek M, Tratar G, et al
    Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry.
    PLoS One. 2016;11:e0156943.
    PubMed     Text format     Abstract available


  189. HSIAO SH, Chiou KR
    Diastolic Heart Failure Predicted by Left Atrial Expansion Index in Patients with Severe Diastolic Dysfunction.
    PLoS One. 2016;11:e0162599.
    PubMed     Text format     Abstract available


  190. BATSON S, Sutton A, Abrams K
    Exploratory Network Meta Regression Analysis of Stroke Prevention in Atrial Fibrillation Fails to Identify Any Interactions with Treatment Effect.
    PLoS One. 2016;11:e0161864.
    PubMed     Text format     Abstract available


  191. THALER MA, Feurer R, Thaler C, Sonntag N, et al
    Activated Protein C Resistance Does Not Increase Risk for Recurrent Stroke or Death in Stroke Patients.
    PLoS One. 2016;11:e0160382.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: